Search

everythinglearnresearchcommunity

for

Search:↓

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

The market for these drugs is expected to grow.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

The new drug delivery system improves vitiligo treatment by enhancing melanocyte activity and viability.

A 940nm laser effectively reduces inflammation in rat joints.

Polydeoxyribonucleotides may help with healing and anti-aging, but more research is needed.

Combining laser with PRP is more effective for vitiligo than PRP alone.

Dietary lipids affect inflammation and are crucial for normal cell function and immune health.

15d‐PGJ2 cream protects against UVB-induced skin damage in mice.

Platelet-rich plasma with a new carrier significantly increases hair thickness without serious side effects.

Platelet-rich plasma (PRP) effectively improves acne scars.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

Laser treatment combined with platelet-rich plasma is more effective for hair loss than laser treatment alone.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

Dutasteride is approved to help manage prostate enlargement.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

The document concludes that injecting platelet-rich plasma can effectively treat androgenetic alopecia, a type of hair loss.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

Platelet-rich plasma might help tissue regeneration in dentistry, but results vary and more research is needed.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

Platelet-rich plasma is as effective as mineral trioxide aggregate for pulp capping and may offer better cellular responses.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

ALRN-6924 may prevent hair loss caused by chemotherapy.